2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Endocrine, Nutritional And Metabolic Diseases, And Immunity Disorders 240-279 > Other Metabolic Disorders And Immunity Disorders 270-279 > Disorders Of Lipoid Metabolism 272.* > 2008 ICD-9-CM Diagnosis 272.1
Pure hyperglyceridemia On October 1, 2008 the 2009 ICD-9-CM codes came into effect. Therefore, this code may be out of date.
The 2009 version of ICD-9-CM 272.1 can be accessed here. - A familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL. It is considered to be an autosomal dominant trait.
- 272.1 is a specific code that can be used to specify a diagnosis
- 272.1 contains 20 index entries
- View the ICD-9-CM Volume 1 272.* hierarchy
272.1 also known as:- Endogenous hyperglyceridemia
- Fredrickson Type IV hyperlipoproteinemia
- Hyperlipidemia, Group B
- Hyperprebetalipoproteinemia
- Hypertriglyceridemia, essential
- Very-low-density-lipoid-type [VLDL] hyperlipoproteinemia
Index entries containing 272.1:- Elevation
- triglycerides
272.1 Findings, abnormal, without diagnosis (examination) (laboratory test) 796.4- triglycerides 272.9
- high
272.1- with high cholesterol 272.2
High- triglycerides
272.1- with high cholesterol 272.2
Hyperglyceridemia 272.1- endogenous
272.1
- essential
272.1
- familial
272.1
- hereditary
272.1
- mixed 272.3
- pure
272.1
Hyperlipidemia 272.4- carbohydrate-induced
272.1
- endogenous
272.1
- group
- B
272.1
Hyperlipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.4- Fredrickson type
- IV
272.1
- very-low-density-lipoid-type [VLDL]
272.1
Hyperprebetalipoproteinemia 272.1- with chylomicronemia 272.3
- familial
272.1
Hypertriglyceridemia, essential 272.1 Lipoproteinemia (alpha) 272.4- hyper-pre-beta
272.1
Prebetalipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.1- with chylomicronemia 272.3
Xanthoma(s), xanthomatosis 272.2- with
- hyperlipoproteinemia
- type IV
272.1
|
|
|